Wegovy Expands Globally While Novo Nordisk Tests Lower Doses to Address Side Effects and Access Concerns

# Wegovy's Next Chapter: Lower Doses, New Markets, and the Global Access Divide **Episode Description:** Wegovy is entering a pivotal new phase—and this episode breaks down everything you need to know. From Novo Nordisk's landmark OASIS 5 trial testing lower-dose semaglutide pills to Mexico's historic approval of the Wegovy tablet, we explore how this blockbuster weight-loss drug is evolving from a single injectable pen into a global oral franchise. In this episode, we cover: - **The OASIS 5 trial**: Why Novo Nordisk is testing smaller doses of oral semaglutide in 450 participants, and what it means for side effects, supply, and cost - **Global expansion**: Mexico becomes the first Latin American country to approve the 25mg Wegovy tablet, joining the US, UAE, UK, and soon Germany - **Record sales**: Wegovy pill sales hit 3.22 billion Danish kroner in Q2 2026 as Novo Nordisk raises its full-year outlook - **Emerging competition**: Poland's Celon Pharma reveals bioequivalence data for its semaglutide rival, Reduzek - **The coffee warning**: Why doctors say your morning brew could undermine your Wegovy pill's effectiveness - **Healthcare disruption**: A JAMA study reveals bariatric surgeries dropped 34% while GLP-1 medication use surged 140% - **The insurance divide**: While France commits to reimbursing Wegovy for one million patients, US employers are cutting coverage—creating a fractured global access landscape Whether you're a patient, healthcare provider, investor, or simply following the GLP-1 revolution, this episode unpacks the science, business strategy, and policy decisions reshaping how the world treats obesity and cardiovascular risk. **Keywords**: Wegovy news, semaglutide pill, Novo Nordisk OASIS 5 trial, oral Wegovy dosage, GLP-1 medications, weight loss drug coverage, Wegovy Mexico approval, obesity treatment 2026, Ozempic alternatives, France Wegovy reimbursement *Subscribe for weekly deep dives into the medical innovations reshaping Some great Deals https://amzn.to/49SJ3Qs For more check out http://www.quietplease.ai